The human heart has the least regenerative capabilities among tissues and organs, and
heart disease continues to be a leading cause of mortality in the industrialized world with …

Long non-coding RNAs (lncRNAs) are non-coding RNAs with lengths> 200 nt and are
involved in the occurrence and development of cardiovascular diseases (CVDs). Exosomes …

Congenital heart disease (CHD) is the most common birth defect among newborns
worldwide and contributes to significant infant morbidity and mortality. Owing to major …

Cardiovascular diseases (CVDs) are the leading cause of mortality and morbidity globally,
representing approximately a third of all deaths every year. The greater part of these cases …

Background Fat grafting, as a standard treatment for numerous soft tissue defects, remains
unpredictable and technique-dependent. Human adipose-derived stem cells (hADSCs) are …

Cardiogenesis relies on the precise spatiotemporal coordination of multiple progenitor
populations. Understanding the specification and differentiation of these distinct progenitor …

The WNT/β‐catenin pathway is a master regulator of cardiac development and growth, and
its activity is low in healthy adult hearts. However, even this low activity is essential for …

Cardiogenic growth factors play important roles in heart development. Placental growth
factor (PLGF) has previously been reported to have angiogenic effects; however, its potential …

This two-paper Series focuses on recent advances and applications of regenerative
medicine that could benefit paediatric patients. Innovations in genomic, stem-cell, and tissue …

Birth defects contribute to∼ 0.3% of global infant mortality in the first month of life, and
congenital heart disease (CHD) is the most common birth defect among newborns …